Diabetes distress is the emotional weight of living with and managing diabetes day after day: the fatigue of testing, dosing and counting, the worry about complications, and the sense that the condition never takes a day off. It is not a psychiatric disorder, and it is not weak willpower. It is a normal, expected reaction to a burden that does not stop. The distinction matters because the wrong name leads to the wrong answer: someone labelled "depressed" may be offered a treatment that does not address the cause, and someone labelled "non-compliant" is handed a guilt that makes everything worse.
On 15 September 2026 the European Association for the Study of Diabetes (EASD) published the first evidence-based clinical guideline in its history — and it was not about a drug or a device. It was about diabetes distress. This article explains what distress is, how it is measured, what trials have actually shown reduces it, and exactly where the evidence runs out.
What is diabetes distress, precisely?
The EASD 2026 guideline defines it as "a specific and natural response to the relentlessness, frustrations and challenges of diabetes," and states explicitly that it is "not a diagnosable mental health condition and requires a different therapeutic approach." Put plainly: there is no psychiatric patient in this picture. There is a person carrying a daily job that never ends.
That is exactly why the US Centers for Disease Control and Prevention (CDC) makes a striking statement: unlike depression, diabetes distress "can't be treated effectively with medicine." This is not a reason to stop any medication. It is a clarification: what hurts here is the burden itself, so what helps must target the burden.
The CDC describes the experience in words many people recognise — feeling "discouraged, worried, frustrated, or tired of dealing with daily diabetes care" — and estimates that in any 18-month period, 33% to 50% of people with diabetes experience it.
Why is the distinction from depression the whole point?
Here sits the most important number in this article. In a review by Fisher, Gonzalez and Polonsky in Diabetic Medicine in 2014, results from the "3D" study were reported: 84.1% of people with moderate or high diabetes distress did not meet criteria for a diagnosis of major depressive disorder. In the other direction, 66.7% of those who did meet criteria for MDD also reported moderate or high distress.
Read that first figure again. The overwhelming majority of people carrying this weight are not clinically depressed. The authors write that diabetes distress "does not assume psychopathology nor is diabetes distress necessarily considered a co-morbid psychiatric disorder," and that — unlike MDD — it "implies aetiology… it is defined by the context of diabetes and its management."
But this does not mean depression isn't real
Now the brake has to be applied hard in the opposite direction, because this message is easy to misread. The CDC states that people with diabetes are two to three times more likely to have depression than people without it, and that only 25% to 50% of those with both are diagnosed and treated — while treatment, "therapy, medicine, or both — is usually very effective." People with diabetes are also 20% more likely to experience anxiety.
So the precise conclusion is not "what you feel isn't depression." It is: these are two different things with two different paths, and confusing them causes harm in both directions — treating ordinary distress as a mental illness, or leaving a real depression untreated because it seems "normal with diabetes."
How many people carry this?
In a meta-analysis by Perrin, Davies, Robertson, Snoek and Khunti (Diabetic Medicine 2017;34(11):1508–1520) covering 55 studies and 36,998 participants with type 2 diabetes, the pooled prevalence of diabetes-specific emotional distress was 36% (95% CI 30.8%–41.3%).
The figure deserves an honest caveat, though. The authors themselves report high heterogeneity between studies, note that "the field of diabetes-distress is a relatively new one," and flag inconsistency in the scales used. Note too that prevalence rose to 45% in female-majority samples and to 56% in samples where comorbid depression was common, while falling to 17% where it was rare — the two conditions genuinely overlap, exactly as the previous section said.
How do you measure something "emotional" this precisely?
This is the step that turns an impression into care. Diabetes distress has validated instruments, and two are used across the American Diabetes Association's own clinical tools:
- The Diabetes Distress Scale (DDS-17): seventeen statements, summed and divided by the number of items. Scores of 1–1.9 indicate low distress, 2–2.9 moderate distress, and 3.0 or greater severe diabetes distress.
- The Problem Areas in Diabetes (PAID) scale: items are summed and multiplied by 1.25 for a score out of 100, where 40 and above indicates severe distress.
There is also a gentler, more practical rule than the total score: any single item scored 3.0 or greater counts as "moderate to severe distress" and, in the ADA's wording, "need[s] to be discussed during the appointment following completion of the questionnaire." The source of the distress may be one specific item — fear of hypoglycaemia, for instance — rather than life as a whole.
The DDS-17 splits distress into four domains: emotional burden, regimen-related distress (testing, dosing, food), physician-related distress, and interpersonal distress (family and those around you). The split matters because each domain has a completely different remedy.
What do the two new guidelines say?
The EASD 2026 guideline recommends that healthcare professionals "assess and monitor diabetes distress at regular intervals, at least annually, and during significant life events and major treatment changes," and that the conversation begin with "open-ended questions, framed around the emotional burden or challenges of living with diabetes." Where elevated distress is found, the clinician should "make a joint plan with the person living with diabetes about next steps."
The American Diabetes Association's Standards of Care in Diabetes—2026, meanwhile, added to its Section 5 a recommendation that screening for anxiety — and for fear of hypoglycaemia in those at risk — be done at least annually, that screening be repeated "when treatment goals are not met, at transitional times and/or in the presence of diabetes complications," and that "referral to a behavioural therapist should be considered if diabetes distress is not adequately dealt with in the consultation."
What do the Saudi numbers say?
In a study published in the Eastern Mediterranean Health Journal (Soliman, Naguib, Neimatallah and colleagues, 2025;31(6):404–415) of 269 patients with type 1 and type 2 diabetes at a tertiary hospital outpatient department in Riyadh, using the validated Arabic DDS-17: 12.3% had high distress, 38.7% moderate distress, and 49.0% little or none. The leading domain was regimen-related distress (22.7%), followed by emotional burden (15.6%).
In a geographically broader study in Cureus (Aljohani, Almoghamsi, Alzaman, Alharbi and Bin Faidh, 2023;15(4):e37525) of 356 adults with type 1 diabetes across all five regions of the Kingdom, 53.4% showed high diabetes distress — and once again the top domain was the regimen (60%), followed by physician-related distress (55%).
The gap between 12.3% and 53.4% is large, and deserves explanation rather than dismissal: the samples differ (clinic attendees versus a national type 1 sample), neither used random sampling, and the version of the scale was not the same. The numbers differ; the direction does not. In both studies the most painful domain is the regimen itself — the daily task, not the disease as an idea.
The authors' own limitations, in their words: the Riyadh team writes that "the cross-sectional design limits causal inferences and the non-probability sampling method may further limit the generalisability of the results," and that an interviewer-administered questionnaire "might have introduced response bias." The Cureus team writes that its cross-sectional design with convenience sampling "may not represent the entire profile of diabetes distress among Saudi patients throughout the whole country."
And note one thing that is easy to exaggerate: the relationship with HbA1c was weak in the Riyadh study (r = 0.15, P = 0.02), and the difference in means in the Cureus study was 7.93% versus 7.55% (P = 0.038). Statistically real, practically modest. Distress deserves attention because it hurts — not because it will fix your lab results.
What actually helps — and where does it stop?
The good news is that this distress responded to intervention in real trials.
In REDEEM (Fisher, Hessler, Glasgow and colleagues, Diabetes Care 2013;36(9):2551–2558), 392 adults with type 2 diabetes who were not clinically depressed were randomised to three arms for 12 months. Distress fell in all three groups (mean DDS from 2.40 to 1.98; regimen distress from 3.04 to 2.34; P < 0.001), with no meaningful differences between arms — except that people who started with high regimen distress benefited more from the distress-specific intervention (P = 0.005).
In T1-REDEEM (Fisher, Hessler, Polonsky and colleagues, Diabetes Care 2018;41(9):1862), 301 adults with type 1 diabetes attended a full-day workshop plus four online meetings over three months. The effect size on distress was large (d = 1.06) and 78.4% achieved a reduction of at least one minimal clinically important difference — and once again there was no difference between the emotion-focused and the educational arms. HbA1c showed "significant but modest reductions," and the association between falling distress and better glucose was weak (r = 0.14, P = 0.01).
And here is the most important brake, taken from the guideline itself: the EASD 2026 recommendations on psychological interventions are conditional, with low to very low certainty of evidence (standardised mean difference −0.21 for psychological interventions in type 1 diabetes). The guideline even issues a conditional recommendation against psychoeducational interventions in type 1 diabetes on very low certainty, while supporting psychological, psychoeducational and educational interventions in type 2 — also conditionally. For type 1 it additionally supports, conditionally, continuous glucose monitoring and automated insulin delivery as ways to reduce distress.
What does that mean in practice? That attending to distress is not a luxury, but nobody holds a guaranteed recipe. As EASD President Francesco Giorgino put it when the guideline was released: "Despite huge advances in therapies and technologies, the emotional burden of diabetes has not eased – for many, it has grown."
The words we use are part of the problem
In the "Language matters" paper (Lloyd, Wilson, Holt, Whicher and Kar, on behalf of the Language Matters Group, Diabetic Medicine 2018), the authors write that negative terms such as "uncontrolled," "non-compliant" or "non-adherent" are common in diabetes care and "can lead to a disconnect between the person with diabetes and the clinician." More importantly: "Feelings of shame or of being judged, and the experience of stigma are likely to lead to lack of engagement with health services and can increase the chance of developing diabetes-related distress."
Blame, in other words, is not merely an unkind style. It is a risk factor. And this applies to family and friends even more than to the clinic: "you shouldn't have eaten that" is offered as advice and lands as a verdict.
Michelle Law, who lives with type 1 diabetes and contributed to the EASD guideline, summarised the problem in a sentence: "Healthcare professionals sometimes mistake diabetes distress for depression. But it's different – these feelings relate specifically to managing a condition."
Practical steps for this week
- Name what you feel. Knowing it has a name, a scale and an international guideline changes a great deal: you are not alone, and you are not failing.
- Identify the domain, not "everything." Is the weight in testing and dosing? In fear of hypoglycaemia? In comments from people around you? In your relationship with your clinician? Each has a different answer.
- Write down the hardest item and take it to your next appointment. This is the rule the ADA's own tools use: any item that distresses you should be discussed at the following visit.
- Ask for one or two goals — no more. The CDC explicitly advises focusing on "one or two small management goals" instead of fixing everything at once.
- Reduce the number of daily decisions. A fixed breakfast with known numbers is one fewer decision in a day full of them.
- Revisit the technique itself. A great deal of regimen-related distress comes from fixable details — injection technique and site rotation among them.
- Move as much as you can, not as much as you're told. Regular exercise was associated with lower distress in the Riyadh study, and you do not need a heroic number — see what the evidence actually says about daily step counts.
- Change the language you use about yourself. "A high reading" is information. "I'm a failure" is not.
If the person carrying this weight is a child or teenager, the burden is shared across a family and a school — a different set of handovers, covered separately in our piece on type 1 diabetes in children.
When should you see a doctor?
This article is educational and does not replace medical advice. Speak to your doctor or diabetes team if:
- The exhaustion or frustration persists for weeks, or starts to disrupt your own care (skipping tests, delaying doses, avoiding appointments).
- Signs appear that may point to genuine depression: loss of interest in things you used to enjoy, clear disruption of sleep or appetite, hopelessness or worthlessness.
- Fear of hypoglycaemia is leading you to keep your readings deliberately high — a treatable problem, and one the 2026 Standards now list among what should be screened annually.
- Your treatment has changed or a new complication has appeared; these are precisely the moments the EASD guideline says call for reassessment.
If you have thoughts of harming yourself, seek help immediately rather than waiting for an appointment: go to the nearest emergency department or call emergency services (997 in Saudi Arabia). In Saudi Arabia you can also reach the Ministry of Health call centre on 937 for telephone medical consultation, and the National Center for Mental Health Promotion for mental health services. And never stop a medication your doctor prescribed on the basis of an article.
Where does Bakery 8 stand on this?
Honestly: this is a topic we have no product for. No bread — not ours and not anyone else's — reduces diabetes distress, and no eating pattern, keto or otherwise, removes the testing, the dosing, the fear or the cost. If this were about selling, we would have picked an easier subject.
In fact we should say something harder about our own industry. The vocabulary of "allowed" and "forbidden," of "guilt-free" and "sinfully delicious" — language the entire healthy-baking category profits from — is the same kind of language the "Language matters" paper warns about: it turns food into virtue or sin, and a person into compliant or failing. Food is nutrition information, not a moral verdict. We would rather our products be described by their numbers than by their absolution: read the label, do the maths, decide.
What a product can honestly and narrowly do is this: remove one decision from your day. The CDC advises focusing on one or two small goals; a fixed breakfast with known numbers — a slice of low-carb bread, a little keto granola, or ready crackers instead of a rushed decision — removes one choice out of dozens. Nothing more than that. And if your heaviest burden sits somewhere else, that somewhere else is what deserves the conversation with your doctor, not the bakery shelf.
Frequently asked questions
Is diabetes distress a mental illness?
No. The EASD 2026 guideline states explicitly that it is "not a diagnosable mental health condition and requires a different therapeutic approach," describing it as a natural response to the relentlessness and challenges of diabetes. That does not make it trivial or unimportant; it means the response targets the daily burden and how it is handled, not a psychiatric diagnosis.
How do I tell it apart from depression?
Distress revolves around diabetes specifically: testing, dosing, food, fear of complications. Depression is broader and reaches into all of life — loss of interest, hopelessness, disturbed sleep and appetite. They can co-exist. The final distinction is not yours alone to make: validated scales and a clinician are the route — especially given that 84.1% of those with moderate or high distress in the 3D study did not meet criteria for depression.
Can distress be treated with medication?
The CDC says that unlike depression, diabetes distress "can't be treated effectively with medicine." What has shown an effect in trials are interventions aimed at the burden itself — although the EASD 2026 guideline classifies those recommendations as conditional and of low certainty. If genuine depression is present, treating it is a medical decision that this article does not override.
Does high distress mean my diabetes will get worse?
The relationship exists but is weaker than people expect. In the Riyadh study the correlation with HbA1c was 0.15; in the Cureus study the difference was 7.93% versus 7.55%. In T1-REDEEM, glucose fell "significantly but modestly." Address distress because it hurts and disrupts care, not as a guaranteed way to lower a lab number.
What can I say to a relative with diabetes without making it worse?
Ask rather than assess: "how does your day go with all of this?" beats "did you stick to it?" Avoid words like "uncontrolled" and "non-compliant," which the "Language matters" paper links to stigma and disengagement from health services. Offer specific, small help instead of general advice.
How often should emotional wellbeing be asked about?
The EASD 2026 guideline recommends assessment "at least annually," plus at significant life events and major treatment changes. The ADA's 2026 Standards add annual screening for anxiety and for fear of hypoglycaemia in those at risk, and repeat screening when goals are not met or complications appear.
The bottom line
What many people with diabetes carry is, in most cases, not depression — and in no case weak willpower. It is diabetes distress: a burden with a name, a four-domain scale, a recommendation to screen for it at least annually, and the first clinical guideline in the history of the European Association for the Study of Diabetes. The right name is the first step toward the right answer, because the wrong name leads down the wrong road in both directions.
And if you want one fewer decision in your day, that is something we can honestly help with, without overclaiming: browse our low-carb bread and the rest of the Bakery 8 (مخبز ثمانية) range at our store in Riyadh, Saudi Arabia, and read the numbers for yourself. The rest of the burden deserves a conversation with your doctor — and it is a conversation worth starting today.
References
- EASD Guideline Development Panel (co-chairs: Jane Speight and Richard Holt). "2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes or type 2 diabetes." Diabetologia, 15 September 2026. doi:10.1007/s00125-026-06840-0
- European Association for the Study of Diabetes — press release accompanying the guideline (EurekAlert), September 2026.
- Fisher L, Gonzalez JS, Polonsky WH. "The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision." Diabetic Medicine 2014;31:764–772.
- Perrin N, Davies MJ, Robertson N, Snoek FJ, Khunti K. "The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis." Diabetic Medicine 2017;34(11):1508–1520. doi:10.1111/dme.13448
- Fisher L, Hessler D, Glasgow RE, et al. "REDEEM: a pragmatic trial to reduce diabetes distress." Diabetes Care 2013;36(9):2551–2558.
- Fisher L, Hessler D, Polonsky WH, et al. "T1-REDEEM: a randomized controlled trial to reduce diabetes distress among adults with type 1 diabetes." Diabetes Care 2018;41(9):1862.
- Lloyd CE, Wilson A, Holt RIG, Whicher C, Kar P, on behalf of the Language Matters Group. "Language matters; a UK perspective." Diabetic Medicine 2018.
- Centers for Disease Control and Prevention (CDC). "Diabetes and Mental Health."
- American Diabetes Association. "Standards of Care in Diabetes—2026," Section 5 (Facilitating Positive Health Behaviors and Well-being), and the accompanying press release.
- American Diabetes Association. "Mental Health Toolkit" — the DDS-17 and PAID questionnaires with their scoring instructions and cut points.
- Soliman ES, Naguib R, Neimatallah F, et al. "Diabetes-related distress among type 1 and type 2 diabetes patients in Saudi Arabia." Eastern Mediterranean Health Journal (EMHJ) 2025;31(6):404–415.
- Aljohani AA, Almoghamsi EY, Alzaman N, Alharbi MB, Bin Faidh AJ. "Diabetes distress among adults with type 1 diabetes mellitus in Saudi Arabia." Cureus 2023;15(4):e37525. doi:10.7759/cureus.37525
Related keywords: diabetes distress, diabetes burnout, depression and diabetes, DDS-17 scale, emotional burden of diabetes, fear of hypoglycemia, mental health with diabetes, EASD 2026 guideline.